drugset / Trial / NCT00203736

A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria

NCT00203736

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the efficacy of sulfadoxine-pyrimethamine plus artesunate with that of sulfadoxine-pyrimethamine on its own for the treatment of uncomplicated malaria.

Timeline

Start
2003-01
Primary completion
Completion
2003-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Artesunate Small molecule 4 mg/kg
Subject pyrimethamine Small molecule 1.25 mg/kg
Subject sulfadoxine Small molecule 25 mg/kg

Indications